NIH-funded research R21 grant

How antibody formulations behave in subcutaneous injections

Official title: SAXS-Guided Coarse-Grained Model Development to Elucidate Antibody-Antibody Interactions for Subcutaneous Drug Delivery

Funded at The Trustees of the Stevens Institute of Technology · NIH-11453934 · Data updated 2026-11-12

A project aims to build computer models that link antibody sequences to how they move and clump in high-concentration solutions used for subcutaneous shots.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionThe Trustees of the Stevens Institute of Technology
NIH-funded
Lab location1 site (Hoboken, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$192,765
NIH project number1R21AI196601-01A1
Project IDNIH-11453934 on NIH RePORTER

Who could benefit from this research

Could help

Patients who receive high-concentration antibody therapies via subcutaneous injections could benefit from improved formulations.

Less likely to help

If a specific antibody formulation is not suitable for a patient’s regimen, they may not experience direct benefit from this project.

What this research studies

If funded, researchers will combine experimental data from small-angle X-ray scattering with measurements of viscosity and aggregation to train a machine learning–based coarse-grained model. The goal is to predict how different antibody sequences will behave in formulations that are injected under the skin, helping design better, more injectable drugs. This patient-facing research could lead to safer, more convenient antibody therapies with fewer needle-related issues.

Why it matters

Potential benefit: Potentially smoother, more reliable subcutaneous antibody injections for patients.

How similar studies have gone: Previous work has used computational models to study protein interactions, but this project aims to improve predictive accuracy with ML-guided parameters and SAXS data.

Where this research is happening

  • The Trustees of the Stevens Institute of Technology
    Hoboken, United States
    Active

Researchers

  • Principal investigator: Lai, Pin-Kuang — The Trustees of the Stevens Institute of Technology
  • Study coordinator: Lai, Pin-Kuang

Related research

Other NIH-funded projects on the same topics.

  • Deep learning tool to diagnose retinopathy of prematurity in newborns

    A new AI-based diagnostic tool uses eye images from premature babies to help clinicians identify treatment-needed retinopathy of prematurity.

    NIH research The Trustees of the Stevens Institute of Technology · Hoboken, United States · NIH-11401397

  • At-home balance game with musical biofeedback for older adults

    A home-based game uses musical biofeedback to help older adults practice weight-shifting and improve balance to reduce fall risk.

    NIH research The Trustees of the Stevens Institute of Technology · Hoboken, United States · NIH-11373903

  • Transitioning Pediatric-to-Adult Care for Children with Medical Complexity

    A project to understand and improve how kids with medical complexity move from pediatric to adult healthcare, helping families and clinicians plan a safer, smoother transition.

    NIH research The Trustees of the Stevens Institute of Technology · Hoboken, United States · NIH-11360865

  • Understanding how nanoscale bone composition affects osteoporosis

    This study is looking at how the tiny structure of bone affects its strength in people with osteoporosis, and by providing bone samples, you can help us find better ways to diagnose and treat this condition.

    NIH research The Trustees of the Stevens Institute of Technology · Hoboken, United States · NIH-11212348

  • AI tool to detect retinopathy of prematurity in preterm infants

    Using artificial intelligence to help doctors spot sight-threatening retinopathy in premature babies.

    NIH research The Trustees of the Stevens Institute of Technology · Hoboken, United States · NIH-11164687

  • Finding Early Signs of Diabetic Eye Damage

    This project is developing a new way to find early signs of eye damage from diabetes, even before vision problems start.

    NIH research The Trustees of the Stevens Institute of Technology · Hoboken, United States · NIH-11091494

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.